Skye Bioscience
SKYE
SKYE
75 hedge funds and large institutions have $39.3M invested in Skye Bioscience in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3.36% less ownership
Funds ownership: 83.09% → 79.73% (-3.4%)
11% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 19
45% less capital invested
Capital invested by funds: $71.3M → $39.3M (-$32M)
Holders
75
Holding in Top 10
3
Calls
$84K
Puts
$21K
Top Buyers
| 1 | +$309K | |
| 2 | +$147K | |
| 3 | +$146K | |
| 4 |
LPL Financial
San Diego,
California
|
+$126K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$55.8K |
Top Sellers
| 1 | -$708K | |
| 2 | -$372K | |
| 3 | -$250K | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
-$224K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$140K |